EichorEICHOR
Location: Stamford Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Stamford

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Ki Health Partners LLC DBA New England Institute for Clinica · H. Lundbeck A/S · NCT05897320
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · New England Institute Neurology and Headache, Merz Investiga · Merz Therapeutics GmbH · NCT07018700
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living
Phase 3 · Kailera Clinical Site · Kailera · NCT07284979
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · NRG Oncology · NCT05174169
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Stamford Therapeutics Consortium · Eli Lilly and Company · NCT06672549
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Out
Phase N/A · Stamford Hospital · Novartis Pharmaceuticals · NCT07091019
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · Alliance for Clinical Trials in Oncology · NCT06876714
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene M
Phase 2 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT05806515
E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Stamford Hospital/Bennett Cancer Center · NRG Oncology · NCT06748222
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · New England Institute Neurology and Headache, Merz Investiga · Merz Therapeutics GmbH · NCT07018713
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · Stamford Therapeutics Consortium · Eli Lilly and Company · NCT07589608
STOP AF First Post-Approval Study
Phase N/A · Cardiology Associates of Fairfield County · Medtronic Cardiac Ablation Solutions · NCT05227053
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Stamford Hospital/Bennett Cancer Center · Alliance for Clinical Trials in Oncology · NCT06632977
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Phase 3 · Ki Health Partners LLC DBA New England Institute for Clinica · H. Lundbeck A/S · NCT04965675
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05256225
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1013 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Phase 4 · Upsher-Smith Clinical Trial Site #1 · Upsher-Smith Laboratories · NCT04748601
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · NRG Oncology · NCT04852887
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1012 · Anthos Therapeutics, Inc. · NCT05712200
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advance
Phase 3 · Research Site · AstraZeneca · NCT06627647
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT06058377
A Study of Buntanetap in Participants With PD
Phase 2/Phase 3 · New England Institute for Clinical Research (Ki Health Partn · Annovis Bio Inc. · NCT07284784
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05987241
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr
Phase 3 · Stamford Hospital ( Site 0049) · Merck Sharp & Dohme LLC · NCT06312176
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1013 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagn
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT06022939
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · National Cancer Institute (NCI) · NCT05675410
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management
NA · Legacy Medical Consultants · NCT06420245
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Smilow Cancer Hospital Care Center at Long Ridge · SWOG Cancer Research Network · NCT06616584
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Stamford Hospital/Bennett Cancer Center · SWOG Cancer Research Network · NCT03418961
Look up another city
Look up another condition